March 5, 2026

Eczema, Exit, Repeat: The Business Model of Chronic Disease

Eczema, Exit, Repeat: The Business Model of Chronic Disease

Barbara Paldus built biotech for a living. Then a serious mental health scare involving her young son forced her to rethink everything. This moment pushed her from manufacturing cancer therapeutics into the $100,000,000,000 skin care industry after she realized most of it runs on marketing and almost no regulation.

We talk about steroid ladders that leave patients worse, why Europe regulates ingredients we still rub on open skin, and how chemo recreates the same barrier damage seen in eczema. She explains how parents end up doing their own clinical trials at home because nobody else will.

We also learned she vaporized her parents' kitchen curtains with a cooking torch and executed Barbies with a classroom guillotine, which tells you exactly who you are dealing with.

I wanted her on because she speaks fluent science and fluent parent at the same time. People in treatment need both.

Listen to this episode. Then do me a solid—leave a review. Tell Apple or Spotify what you really think. Five stars help us reach more people who need to hear these stories. One review makes a bigger difference than you know.

Out of Patients is proudly the #1 independent healthcare podcast worldwide. New episodes every Tuesday. We’ve been turning medical trauma into momentum for 17 years. Subscribe wherever you get your podcasts.